1. Home
  2. LTRX vs TARA Comparison

LTRX vs TARA Comparison

Compare LTRX & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantronix Inc.

LTRX

Lantronix Inc.

HOLD

Current Price

$5.20

Market Cap

247.5M

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

236.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRX
TARA
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.5M
236.1M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
LTRX
TARA
Price
$5.20
$3.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$6.50
$24.40
AVG Volume (30 Days)
1.1M
324.4K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
65.52
38.25
EPS
N/A
N/A
Revenue
$120,899,000.00
$2,948,000.00
Revenue This Year
$1.12
N/A
Revenue Next Year
$15.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.37
$3.02
52 Week High
$8.75
$7.82

Technical Indicators

Market Signals
Indicator
LTRX
TARA
Relative Strength Index (RSI) 39.92 39.12
Support Level $5.08 $3.73
Resistance Level $6.86 $4.17
Average True Range (ATR) 0.36 0.14
MACD -0.08 -0.01
Stochastic Oscillator 2.08 17.91

Price Performance

Historical Comparison
LTRX
TARA

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The company operates in a single operating segment: the development, marketing, and sale of industrial and enterprise IoT products and services. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the U.S, Canada and the Rest of the World. The U.S contribute the vast majority of total revenue.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: